Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shoulder surgery study tests better ways to see inside the joint

NCT ID NCT07442643

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two different approaches to improve how well surgeons can see inside the shoulder during a common repair surgery. 80 adults with full-thickness rotator cuff tears were randomly assigned to receive either epinephrine in the irrigation fluid or intravenous tranexamic acid. The main goal was to see which method gave surgeons a clearer view during the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

May 2021

Finished

Dec 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-70 years * MRI-confirmed full-thickness rotator cuff tear * Planned primary arthroscopic rotator cuff repair * Written informed consent obtained Exclusion Criteria: * Age \>70 years * Advanced cardiovascular disease (advanced heart failure, uncontrolled hypertension, active ischemic heart disease) * Significant renal impairment * History of thromboembolic disease * Contraindication to tranexamic acid * Irreparable massive tear with advanced fatty degeneration or severe muscle atrophy * Revision surgery * Planned concomitant open surgery

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rotator cuff tear are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Rotator Cuff Injuries rotator cuff syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Umraniye Training and Research Hospital

    Istanbul, 34766, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.